• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2012 Fiscal Year Final Research Report

Elucidation of the mechanisms underlying in the immunological abnormalities of lysosomal storage diseases

Research Project

  • PDF
Project/Area Number 23790448
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Experimental pathology
Research InstitutionYokohama City University

Principal Investigator

YAMAGUCHI Akira  横浜市立大学, 横浜市立大学, 客員研究員 (20381585)

Project Period (FY) 2011 – 2012
Keywordsライソゾーム病 / 自己抗体 / 炎症反応 / ケモカイン
Research Abstract

We have previously found that the progress neurologic disease induced in SD and hex-/- mice, is associated with the production of pathogenic anti-glycolipid autoantibodies. In this study, we focused immunological abnormalities in the CNS. We employed Real-time PCR analysis to monitor gene expression in the terminal stage of hexb-/- mice and found that gene associated with the immune responses were up-regulated. B lymphocyte chemoattractant CXCL-13 was one of there up-regulated genes and is expressed specifically in the CNS. To determine the role of the CXCL-13, the cxcl-13 gene was additionally disrupted in hexb-/- mice, as it play a key role in the autoimmune disease. Clinical symptoms were improved and life spans were extended in the hexb-/-, cxcl-13-/- mice and the number of neuronal cells was also increased than hexb-/- mice. These findings suggest that the expression of CXCL-13 plays an important role in the pathogenesis of neuropathy in hexb-/- mice and therefore provides a target for novel therapies.

  • Research Products

    (1 results)

All 2012

All Presentation (1 results)

  • [Presentation] サンドホフ病モデルマウスにおけるα-シヌクレインの機能と病態への関与2012

    • Author(s)
      鈴木京子、山口章、神崎誠一、都甲崇、勝瀬大海、青木直哉、河上緒、山口佳代子、幸光範子、藤田雅代、橋本款、山中正二、平安良雄
    • Organizer
      第85回日本生化学会大会
    • Place of Presentation
      福岡国際会議場(福岡県)
    • Year and Date
      2012-12-16

URL: 

Published: 2014-09-25  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi